መነሻ › የጡንቻ ካንሰር › ሜሪላንድ

በሜሪላንድ ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 68 ጥናቶች በሜሪላንድ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በሜሪላንድ ውስጥ ያሉ ከተሞች

Official study text (English)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Mercy Medical Center, Baltimore
Maryland Oncology Hematology P A, Silver Spring

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Medical Center, Baltimore
Sinai Hospital of Baltimore, Baltimore
MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
እና 10 ተጨማሪ

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT01441089

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 72 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT01174121

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07619534

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Johns Hopkins University, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06172478

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Maryland Oncology Hematology, Laurel

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07102381

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

Maryland Proton Treatment Center, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 19 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05856773

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Maryland Proton Treatment Center, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 50 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT01766297

Collection of Blood From Patients With Cancer

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT00034216

Genomic Services Research Program

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

1 Month – 105 Years · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT02595957

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 72 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT03412877

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Mercy Medical Center - Baltimore ( Site 0015), Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06966700

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Greenebaum Comprehensive Cancer Center ( Site 0036), Baltimore
Holy Cross Hospital ( Site 0073), Silver Spring

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Columbia

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Annapolis
Clinical Trial Site, Baltimore
Clinical Trial Site, Baltimore
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

American Oncology Partners, PA, Bethesda
James M Stockman Cancer Institute, Frederick

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

United Theranostics, Glen Burnie

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Medstar Research Institute, Hyattsville

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05894239

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Saint Agnes Hospital, Clinical Research Center, Baltimore
Maryland Oncology Hematology P.A., Columbia

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Mercy Medical Center, Baltimore
Ascension St. Agnes Hospital, Baltimore
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05123482

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Maryland Oncology Hematology - Annapolis, Annapolis

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07100106

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06982521

Cardiometabolic Screening Program

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT05386719

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06245889

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Velocity Clinical Research, Annapolis
University of Maryland, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

The Vanguard Study: Testing a New Way to Screen for Cancer

Walter Reed National Military Medical Center, Bethesda

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06995898

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

University of Maryland/Greenebaum Cancer Center, Baltimore
Mercy Medical Center, Baltimore
Greater Baltimore Medical Center, Baltimore
እና 17 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06072612

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06764940

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይ

እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT07067138

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06500481

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

National Institutes of Health Clinical Center, Bethesda

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ18 እስከ 72 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT02830724

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Local Institution - 1035, Baltimore

ተሳታዮችን በመፈለግ ላይደረጃ 2/3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06926868

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

Walter Reed National Military Medical Center, Bethesda

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT07140172

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Maryland Oncology Hematology, Annapolis

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05232916

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Maryland Oncology Hematology, Rockville

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

E-Mindfulness Approaches for Living After Breast Cancer

Maryland Proton Treatment Center, Baltimore
University of Maryland/Greenebaum Cancer Center, Baltimore
MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
እና 14 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06748222

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።